The management of dysplastic naevi based on histopathological grading is a contentious issue. Comprehensive management guidelines are lacking and the approach taken varies between clinicians. The authors sought to understand how Australian dermatologists approach the management of biopsy-proven dysplastic naevi, and the impact of grading of dysplasia upon this management.In total, 547 Fellows of the Australasian College of Dermatologists were surveyed and 218 responses were collected (40% response rate).Although all dermatologists surveyed would re-excise an incompletely removed severely dysplastic naevus, opinion was divided over whether to treat such a lesion as an in situ melanoma or a dysplastic naevus, with 55% of respondents using a 5...
Objectives: (1) To assess the incidence of melanoma in a cohort of patients with dysplastic melanocy...
International audienceManagement of congenital melanocytic naevi in childhood may vary depending on ...
Dysplastic nevi (DN) are common and controversial and the best choice for management of DN after dia...
Before the controversies surrounding dysplastic melanocytic nevi are resolved, dermatopathologists m...
BACKGROUND: To date, much confusion exists about the biological significance of dysplastic naevi and...
The current recommendations for treating dysplastic nevi vary based on the degree of dysplasia but o...
Over 26 months, 223 general practitioners recorded consultations involving the management of skin na...
Over 26 months, 223 general practitioners recorded consultations involving the management of skin na...
AIMS: To assess the type of problems encountered in diagnosing melanocytic lesions and to evaluate t...
Many countries have seen a dramatic increase in the reported incidence of cutaneous melanoma in rece...
Aims: To assess the type of problems encountered in diagnosing melanocytic lesions and to evaluate t...
Background We aimed to determine whether the histopathological grading of dysplastic nevi is an obje...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/74999/1/j.1365-2133.2006.07466.x.pd
Objective: To assess changes in the choice of skin biopsy technique for assessing invasive melanoma ...
BackgroundAlthough treatment guidelines exist for melanoma in situ and invasive melanoma, guidelines...
Objectives: (1) To assess the incidence of melanoma in a cohort of patients with dysplastic melanocy...
International audienceManagement of congenital melanocytic naevi in childhood may vary depending on ...
Dysplastic nevi (DN) are common and controversial and the best choice for management of DN after dia...
Before the controversies surrounding dysplastic melanocytic nevi are resolved, dermatopathologists m...
BACKGROUND: To date, much confusion exists about the biological significance of dysplastic naevi and...
The current recommendations for treating dysplastic nevi vary based on the degree of dysplasia but o...
Over 26 months, 223 general practitioners recorded consultations involving the management of skin na...
Over 26 months, 223 general practitioners recorded consultations involving the management of skin na...
AIMS: To assess the type of problems encountered in diagnosing melanocytic lesions and to evaluate t...
Many countries have seen a dramatic increase in the reported incidence of cutaneous melanoma in rece...
Aims: To assess the type of problems encountered in diagnosing melanocytic lesions and to evaluate t...
Background We aimed to determine whether the histopathological grading of dysplastic nevi is an obje...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/74999/1/j.1365-2133.2006.07466.x.pd
Objective: To assess changes in the choice of skin biopsy technique for assessing invasive melanoma ...
BackgroundAlthough treatment guidelines exist for melanoma in situ and invasive melanoma, guidelines...
Objectives: (1) To assess the incidence of melanoma in a cohort of patients with dysplastic melanocy...
International audienceManagement of congenital melanocytic naevi in childhood may vary depending on ...
Dysplastic nevi (DN) are common and controversial and the best choice for management of DN after dia...